Digital health applications (DiGA) are used to detect, monitor, treat, or alleviate the symptoms of diseases. However, in Germany, only those DiGAs that have been approved by the Federal Institute for Drugs and Medical Devices (BfArM) are reimbursed by statutory health insurance funds. Safety and data protection requirements are among the first aspects to be examined. Afterward…
At the 35th Alzheimer Europe Conference in Bologna, Italy, digiDEM Bayern presented its latest research findings through lectures and poster presentations. The overarching theme of this year's international conference for dementia research was „Connecting science and communities: The future of dementia care.“ The conference, held from October 6th to 10th, 2025, at the Bologna Congress Center...
After decades of stagnating research, there's renewed momentum: new monoclonal antibodies against amyloid deposits, such as Lecanemab or Donanemab, are directly targeting the disease mechanisms of Alzheimer's dementia for the first time. Previous medications could only alleviate symptoms, but not slow the progression of the disease. How promising are the new drugs – and…
digiDEM Bayern schreibt eine Erfolgsgeschichte fort: Mit mehr als 3.000 Teilnehmenden hat das größte Demenzregister Deutschlands einen neuen Höchststand erreicht. Das vom Bayerischen Staatsministerium für Gesundheit, Pflege und Prävention (StMGP) geförderte Leuchtturmprojekt zählt damit zugleich zu den größten europäischen Vorhaben zur Erfassung von Langzeitdaten im Bereich der Versorgungsforschung zu Demenzen. …
Anlässlich des 24. Deutschen Kongresses für Versorgungsforschung (DKVF) in Hamburg hat digiDEM Bayern zu seinem wissenschaftlichen Symposium eingeladen. Auf dem Campus des Universitätsklinikums Eppendorf (UKE), wo der DKVF vom 22. bis 24. September 2024 stattfand, präsentierten die digiDEM Bayern-Forschenden aktuelle Forschungsergebnisse. An der Veranstaltung des Deutschen Netzwerks Versorgungsforschung (DNVF) nahmen mehr als 1.100 Versorgungsforschende, …
Researchers from China found that 62 percent of surveyed older high-risk individuals were willing to participate in dementia screening. However, only 12 percent actually underwent the test. The researchers cited psychological factors as the explanation for this discrepancy. Almost 40 percent of dementia cases can be prevented or...
Dementia prevention at the municipal level – how can it succeed? A study from the USA investigated how older people deal with their test results and the information they received after the test. More than half of the study participants shared their screening results with their families, and a good third informed...
Dementia screening by primary care physicians: What are the risks and benefits? Researchers in the USA have investigated in a study whether targeted dementia testing for older people has advantages or disadvantages. It was previously unclear whether primary care screening for dementia offers more benefits to older people...
Those who take a dementia self-test don't know exactly what lies ahead. For some, a dementia screening can also be associated with mental strain. Researchers from Sweden have investigated the significance of anxiety in dementia self-tests in a study. Dementia self-tests are considered a good way to promote early dementia diagnosis and…
Despite the benefits of early dementia detection, many people worldwide hesitate to undergo dementia screening. Researchers from Singapore have identified eight main factors in a recent study that influence the willingness to have one's memory tested. In their study, published in July 2025, the researchers found...
